Skip to content

Specific Modified Exercise Program for Patients Having Chronic Asthma

Effects of Moderate Intensity Interval Training and Sprint Interval Training on Patients Having Chronic Asthma.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06197737
Enrollment
78
Registered
2024-01-09
Start date
2023-03-01
Completion date
2024-01-01
Last updated
2024-05-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Asthma

Brief summary

To compare the effects of moderate intensity interval training and sprint interval training on patients having chronic asthma.

Detailed description

Chronic asthma is a complex heterogeneous disease characterized by multiple aggravating factors. Asthma is treated with two types of medicines , long term medicines and quick relieve medicine. Although the relationship between asthma and the effects of HIIT/SIT were studied in the literature, there was not one comparing the results of these aforementioned studies. The purpose of this study is to find the effects of moderate intensity interval training and sprint interval training on pat determine effects of group wise physical activity on asthma related quality of life. To determine the effects of group wise physical activity on cardiorespiratory endurance

Interventions

Participants in this group will perform moderate intensity interval training in which they will perform stair climbing 3 times a week and for every 1 interval I will ask them to take rest for 3 minutes.

sprint interval training in which they will do stair climbing 3 times a week with a fast pace.

They will be on pharmacological treatment as prescribed by their pulmonologist.

Sponsors

Riphah International University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
15 Years to 25 Years
Healthy volunteers
No

Inclusion criteria

* Patients having chronic asthma * Age between 15-25 years. * Participants having no dyspnea at rest . * Participants scoring 13 or less on borg scale *

Exclusion criteria

* History of co-morbidities. * History of recent fractures. * Participants scoring greater than 13 on BORG scale

Design outcomes

Primary

MeasureTime frameDescription
Assessment of change in the Inspiratory CapacityBaseline, 8th week and then 16th weekIt will measured using an incentive spirometer
Assessment of change in the Pulmonary FunctionBaseline, 8th week and then 16th weekElectronic spirometer will be used to measure all the parameters of pulmonary function.
Assessment of change in the Oxygen saturationBaseline, 8th week and then 16th weekMeasured using pulse oximeter before, during and after the intervention.
Assessment of change in the Rate of perceived exertion / dyspneaBaseline, 8th week and then 16th weekmeasured through borg scale during the assigned intervention
Assessment of change in the cardiovascular enduranceBaseline, 8th week and then 16th weekPACER test for cardiovascular endurance test

Countries

Pakistan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026